[go: up one dir, main page]

BR9402201A - Solução oftálmica e método para tratar o olho contra irritação e secura - Google Patents

Solução oftálmica e método para tratar o olho contra irritação e secura

Info

Publication number
BR9402201A
BR9402201A BR9402201A BR9402201A BR9402201A BR 9402201 A BR9402201 A BR 9402201A BR 9402201 A BR9402201 A BR 9402201A BR 9402201 A BR9402201 A BR 9402201A BR 9402201 A BR9402201 A BR 9402201A
Authority
BR
Brazil
Prior art keywords
dryness
treat
ophthalmic solution
eye against
against irritation
Prior art date
Application number
BR9402201A
Other languages
English (en)
Inventor
Henry P Dabrowski
Anil Salpekar
William O Lever Jr
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of BR9402201A publication Critical patent/BR9402201A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
BR9402201A 1993-07-02 1994-06-23 Solução oftálmica e método para tratar o olho contra irritação e secura BR9402201A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8642193A 1993-07-02 1993-07-02

Publications (1)

Publication Number Publication Date
BR9402201A true BR9402201A (pt) 1995-03-14

Family

ID=22198460

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9402201A BR9402201A (pt) 1993-07-02 1994-06-23 Solução oftálmica e método para tratar o olho contra irritação e secura

Country Status (4)

Country Link
US (1) US5591426A (pt)
BR (1) BR9402201A (pt)
CA (1) CA2125060C (pt)
MX (1) MX9405006A (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997029741A1 (en) * 1996-02-14 1997-08-21 Alcon Laboratories, Inc. Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials
WO1997028827A1 (fr) 1996-02-07 1997-08-14 Rohto Pharmaceutical Co., Ltd. Composition ophtalmique possedant une viscosite adaptee
EP0929292B1 (en) * 1996-09-20 2001-05-30 Bausch & Lomb Incorporated Method and composition for rewetting contact lenses and relieving eye dryness
US5800807A (en) * 1997-01-29 1998-09-01 Bausch & Lomb Incorporated Ophthalmic compositions including glycerin and propylene glycol
ATE504644T1 (de) * 1997-11-26 2011-04-15 Abbott Medical Optics Inc Verwendung von hydroxypropylmethylcellulose in einem reinigungsmittel für kontaktlinsen
US6063745A (en) 1997-11-26 2000-05-16 Allergan Mutli-purpose contact lens care compositions
US6274626B1 (en) 1998-12-22 2001-08-14 Bausch & Lomb Incorporated Pheniramine-containing compositions and method for treating allergic responses
AR022119A1 (es) * 1998-12-22 2002-09-04 Bausch & Lomb Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas
US6730065B1 (en) * 2000-09-15 2004-05-04 Ocularis Pharma, Inc. Night vision composition
US20020082288A1 (en) * 1999-09-16 2002-06-27 Gerald Horn Ophthalmic formulations comprising an imidazoline
US6420407B1 (en) 1999-09-16 2002-07-16 Gerald Horn Ophthalmic formulation which modulates dilation
US8889112B2 (en) * 1999-09-16 2014-11-18 Ocularis Pharma, Llc Ophthalmic formulations including selective alpha 1 antagonists
US20070104798A1 (en) 1999-10-04 2007-05-10 S.K. Pharmaceuticals, Inc. Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide
CN1413114A (zh) * 1999-12-27 2003-04-23 参天制药株式会社 用于稳定泪液层的体系
JP4618443B2 (ja) * 1999-12-27 2011-01-26 参天製薬株式会社 涙液層の安定化システム
JP3846537B2 (ja) * 1999-12-28 2006-11-15 ライオン株式会社 コンタクトレンズ用装着液
EP1312380B1 (en) * 2000-06-19 2006-05-03 Santen Pharmaceutical Co., Ltd. Aseptics
US20060211753A1 (en) * 2000-11-03 2006-09-21 Ocularis Pharma, Inc. Method and composition which reduces stimulation of muscles which dilate the eye
US9308264B2 (en) * 2000-11-08 2016-04-12 Fxs Ventures, Llc Ophthalmic contact lens solutions containing forms of vitamin B
US6703039B2 (en) * 2000-12-06 2004-03-09 Bausch & Lomb Incorporated Reversible gelling system for ocular drug delivery
US20030133905A1 (en) * 2001-12-20 2003-07-17 Zhenze Hu Composition for treating contact lenses in the eye
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
WO2004028536A1 (en) * 2002-09-30 2004-04-08 Babizhayev Mark A Method for topical treatment of eye disease and composition and device for said treatment
AU2004263009B2 (en) 2003-08-07 2009-12-24 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
ATE442849T1 (de) * 2004-03-18 2009-10-15 R Tech Ueno Ltd Wässrige zusammensetzung mit einem thiazol- derivat
US7169881B2 (en) * 2004-10-29 2007-01-30 Clariant (France) Aminoplast resin compositions
US20100233295A1 (en) * 2005-03-02 2010-09-16 Vibha Gupta Aqueous moisturizers and lubricants and uses thereof
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
WO2007001484A2 (en) * 2005-06-20 2007-01-04 Playtex Products, Inc. Non-irritating compositions
ZA200802546B (en) * 2005-08-29 2009-10-28 Healor Ltd Methods and compositions for prvention and treatment of diabetic and aged skin
US20070280902A1 (en) * 2006-06-01 2007-12-06 Laura Rabinovich-Guilatt Method for treating eye disease or conditions affecting the posterior segment of the eye
EP2185184A2 (en) * 2007-07-30 2010-05-19 HealOr Ltd. Pharmaceutical composition for treating wounds and related methods
AU2008310956B2 (en) 2007-10-08 2014-08-07 Aurinia Pharmaceuticals Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
KR101805852B1 (ko) * 2007-12-04 2018-01-10 산텐 에스에이에스 덱사메타손 팔미테이트와 같은 코르티코스테로이드 전구약물을 포함하는 안과질환 치료용 조성물
AU2010259184B2 (en) * 2009-06-09 2015-08-13 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
CA2789972A1 (en) 2010-01-11 2011-07-14 Healor Ltd. Method for treatment of inflammatory disease and disorder
JP2013543862A (ja) 2010-11-08 2013-12-09 ヒールオア・リミテッド 眼科用緩衝組成物およびその使用方法
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠(olopatadine)眼用組成物
US9089560B2 (en) 2013-02-01 2015-07-28 Ocularis Pharma, Llc Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
DK2950648T3 (da) 2013-02-01 2019-12-02 Ocuphire Pharma Inc Vandige oftalmiske opløsninger af phentolamin og medicinske anvendelser deraf
RU2537034C1 (ru) * 2013-11-29 2014-12-27 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Лечебно-профилактическое средство для гигиенической обработки полости рта у людей, страдающих ксеростомией, обладающее антисептическим действием, в виде спрея, геля и раствора для полоскания рта
KR102539012B1 (ko) 2014-08-20 2023-05-31 실크 테크놀로지스 리미티드 피브로인 유래 단백질 조성물
CN105749360B (zh) * 2016-03-28 2019-06-18 赛克赛斯生物科技股份有限公司 一种保护角膜的组合物及其制备方法与应用
CN109640694A (zh) 2016-04-08 2019-04-16 康奈尔大学 使用丝衍生蛋白质增强伤口愈合的方法
US11242367B2 (en) 2016-08-12 2022-02-08 Silk Technologies, Ltd. Silk-derived protein for treating inflammation
CA3025567C (en) * 2017-04-25 2019-10-22 Wakamoto Pharmaceutical Co., Ltd. Thermo-responsive gelling artificial lacrima
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
EP3866790A4 (en) 2018-10-15 2022-08-03 Ocuphire Pharma, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA AND RELATED DISEASES
CA3116589A1 (en) 2018-10-26 2020-04-30 Ocuphire Pharma, Inc. Methods and compositions for treatment of presbyopia, mydriasis, and other ocular disorders
KR102656181B1 (ko) * 2019-08-27 2024-04-08 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물
CN115368310B (zh) 2021-05-18 2025-06-27 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3311577A (en) * 1965-03-29 1967-03-28 Burton Parsons Chemicals Inc Underwater contact lens solution
US3549747A (en) * 1968-02-20 1970-12-22 Flow Pharma Inc Contact lens wetting solution and method of using same
US3856919A (en) * 1970-06-08 1974-12-24 Burton Parsons Chemicals Inc Ophthalmic solution
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
US3987163A (en) * 1973-07-27 1976-10-19 Burton, Parsons And Company, Inc. Polystyrene sulfonate containing opthalmic solutions
US4029817A (en) * 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
US4013576A (en) * 1973-11-21 1977-03-22 Wesley-Jessen Inc. Contact lens treating composition
US3920810A (en) * 1974-04-23 1975-11-18 Burton Parsons And Company Inc Polyacrylamide containing ophthalmic solutions
US4039662A (en) * 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
US4120949A (en) * 1977-10-05 1978-10-17 Cooper Laboratories, Inc. Ophthalmic solution
US4438123A (en) * 1980-03-04 1984-03-20 Merck & Co., Inc. Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4626292A (en) * 1982-06-01 1986-12-02 Sherman Laboratories, Inc. Soft contact lens wetting and preservation method
US4421748A (en) * 1982-07-13 1983-12-20 Trager Seymour F Artificial tear aid
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma
US4744980A (en) * 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
US5141665A (en) * 1987-03-31 1992-08-25 Sherman Laboratories, Inc. Cleaning, conditioning, storing and wetting system and method for rigid gas permeable contact lenses and other contact lenses
EP0389995B1 (en) * 1989-03-28 1995-05-31 Nisshin Flour Milling Co., Ltd. Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension
US5264449A (en) * 1989-11-13 1993-11-23 Allergan, Inc. N-substituted derivatives of 3R,4R-ethyl-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidinone

Also Published As

Publication number Publication date
US5591426A (en) 1997-01-07
CA2125060A1 (en) 1995-01-03
CA2125060C (en) 1999-03-30
MX9405006A (es) 1995-01-31

Similar Documents

Publication Publication Date Title
BR9402201A (pt) Solução oftálmica e método para tratar o olho contra irritação e secura
FI963696A7 (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
BR9407264A (pt) Composição aquosa e método para tratar lentes de contato
BR9405653A (pt) Solução oftálmica solução aquosa para tratamento de lentes de contato método para tratar lentes de contato e método para preservar uma solução oftálmica
FI960232L (fi) Diklofenaakkiin ja tobramisiiniin perustuva oftalminen liuos ja sen käytöt
BR9700993A (pt) Composição e processo para tratamento tópico de descolorações de pele encontradas abaixo dos olhos composição e processo para tratamento tópico de gordura de pele encontrada abaixo dos olhos
DE69524138D1 (de) Hautbehandlungsmittel
BR8505605A (pt) Processo para tratar condicoes externas do olho humano e implante para o canaliculo do olho humano
BR9610522A (pt) Composição para lavagem do corpo e processo para o tratamento da pele
BR9603544A (pt) Agentes para o tratamento dos cabelos
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
DE69618188D1 (de) Kosmetisches hautbehandlungsverfahren
PT90969A (pt) Dispositivo para banho ocular
FI970489A7 (fi) Paikallisesti käytettäviä silmälääkekoostumuksia, jotka sisältävät dok sepiinijohdoksia ja soveltuvat allergisten silmäsairauksien hoitoon
BR9508584A (pt) Processo para tratamento de um indivíduo para endotoxemia e para alivio utilizável no tratamento de endotoxemia
BR9405698A (pt) Composições tópicas para o olho compreendendo um derivado de beta-ciciodextrina e um agente terapêutico
BR9609297A (pt) Processo para aumentar of fluxor sanguineo na retina
BR8901135A (pt) Composicao para condicionamento de tecido e processo para tratar tecidos
BR9402492A (pt) Composição aquosa para limpeza de pele
DE69528637D1 (de) Hautbehandlungsmittel gegen akne
PT90876A (pt) Processo e aparelho para o tratamento de peles com um fluido
BR9101496A (pt) Processo para tratamento de tecidos
BR9506549A (pt) Derivados de benzilamina contendo grupos nitróxi e sua aplicação para o tratamento de enfermidades cardiovasculares bem como de pressão interna dos olhos elevada
FI905952A7 (fi) Menetelmä ja keinot silmän pupillin supistumisen aiheuttamiseksi tai e stämiseksi
BR9202844A (pt) Agente de tratamento de sementes e processo para tratar sementes

Legal Events

Date Code Title Description
EE Request for examination
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FF Decision: intention to grant
FG9A Patent or certificate of addition granted
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADE(S).

B24H Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)

Free format text: EXTINCAO DEFINITIVA - ART. 78 INCISO IV DA LPI

B24F Patent annual fee: publication cancelled

Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2242 DE 24/12/2013 POR TER SIDO INDEVIDA.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2605 DE 08-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.